Each tablet contains Clomipramine chloride 25 mg.
Lactose monohydrate, Corn starch, Silica colloidal anhydrous, Stearic acid, Talk, Magnesium stearate, Glycerol 85%, Hydroxypropyl metylcellulose, Vinylpyrrolidone/Vinylacetate copolymer, Titanium dioxide, Sucrose cryst., Polyvinylpyrrolidone K30, Dispersed Yellow 15093 Polyethylene glycol 8000, Microcrystalline cellulose.
Slow-released tablets, divisible
Each tablet contains Clomipramine chloride 75 mg.
Calcium hydrogen phosphate dehydrate, Polyacrylate dispersion 30%, Calcium stearate, Silica colloidal anhydrous, Hydroxypropyl metylcellulose, Talk, Titanium dioxide, Polyoxyl 40 hydrogenated castor oil, Red iron oxide.
Treatment of various types of depression. Treatment of obsessive-compulsive disorder (OCD).
Drowsiness, fatigue, dry mouth, headache, blurred vision, dizziness; increased appetite, weight gain; tremor, sweating, sexual function and libido disorders; restlessness, feeling of anxiety, disorientation, confusion, agitation, poor concentration, sleep disturbances, nightmares, irritability, aggressiveness, loss of memory, worsening of depression; yawning, numbness of the hands or feet, hot flushes, dilated pupils; nausea, vomiting; diarrhea, constipation, low blood pressure, EEG and ECG changes, increase of liver enzymes.
Store in a dry place below 25°C.
Novartis Farma, S.P.A, Switzerland.
Anafranil 25: 108 06 24600 00
Anafranil 75: 053 91 26407 00